Crispr Therapeutics: Why I've Become Even More Bullish (Rating Upgrade)
Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...
bovnews16h
Why Did Crispr Therapeutics AG (CRSP) Stock See -12.72% Plunge in the Last 90 Days?
Crispr Therapeutics AG (CRSP) stock saw a modest uptick, ending the day at $40.49 which represents a slight increase of $0.49 or 1.23% from the prior close of $40. The stock opened at $40 and touched ...
Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics today
EST Cathie Wood’s ARK Investment buys 187K shares of Crispr Therapeutics (CRSP) todayMaximize Your Portfolio with Data Driven ...
U.S. Capital Wealth Advisors LLC Raises Stock Holdings in Vanguard Mega Cap Growth ETF (NYSEARCA:MGK)
U.S. Capital Wealth Advisors LLC increased its stake in Vanguard Mega Cap Growth ETF (NYSEARCA:MGK – Free Report) by 1.7% ...
Is VRTX a Portfolio Must Have After Two FDA Nods Ahead of Q4 Earnings?
On Vertex's Q4 earnings call, investors will focus on management's comments about launch preparation for Alyftrek (vanza ...
Vanguard Mega Cap Growth ETF (NYSEARCA:MGK) Stock Holdings Decreased by Blue Trust Inc.
Blue Trust Inc. decreased its stake in shares of Vanguard Mega Cap Growth ETF (NYSEARCA:MGK – Free Report) by 20.5% during ...
Cathie Wood's ARK buys CRISPR, sells Robinhood in daily trades
In the latest trading session, Cathie Wood's ARK ETFs continued to adjust their portfolios, with significant moves seen in both buying and selling across various sectors. The largest transaction for ...
Here are highlights from Wednesday’s Analyst Blog:
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discu ...